Summary
After administration of a loading dose, temocillin was infused intravenously into 5 volunteers for 3 hours (250 and 750 mg/h). A urine flow of more than 500 ml/h was maintained. The mean plasma concentrations were 131.4 and 220.7 mg/L during the lower dose and higher dose infusions, respectively, and protein binding decreased from 83% to 74% with this increase in plasma concentration. The renal clearance of the total drug increased from 29.0 ml/min (low dose) to 50.5 ml/min (high dose) [p < 0.001], but after correction for protein binding the renal clearance of the unbound drug only increased from 169.1 to 197.0 ml/min (not statistically significant). The extrarenal clearance of temocillin was negligible.
Blocking of tubular excretion by probenecid caused a maximum decrease of the renal clearance of temocillin from 34.1 to 22.4 ml/min. This maximum effect of 12.3 ml/min subsided by 1.7 ml/min/h. The renal clearance of the free drug decreased to 134.6 ml/min, slightly less than the creatinine clearance (158.1 ml/min).
It may be concluded that even at high plasma concentrations of temocillin there is no saturation of the tubular transport mechanism, and that tubular excretion plays a relatively minor role in the renal excretion of the drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergan, T.; Thorsteinsson, S.B. and Steingrimsson, O.: Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Chemotherapy 28: 160–170 (1982).
Bins, J.W. and Mattie, H.: Tubular excretion of beta-lactam antibiotics in healthy volunteers and in cystic fibrosis patients. British Journal of Clinical Pharmacology 13: 611 (1982).
Bolivar, R.; Weaver, S.S. and Bodey, G.P.: Comparative in-vitro study of Temocillin (BRL 17421), a new penicillin. Antimicrobial Agents and Chemotherapy 21: 641–645 (1982).
Brown, R.M.; Wise, R. and Andrews, J.M.: Temocillin, in vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers. Journal of Antimicrobial Chemotherapy 10: 295–302 (1982).
Chaon, A.L.; Grady, H.T. and Stanely, M.A.: Determination of creatinine by means of automatic chemical analysis. American Journal of Clinical Pathology 35: 83–88 (1961).
Chen, H.Y. and Williams, J.D.: Temocillin compared to ampicillin against Haemophilus influenzae and to other penicillins against intestinal aerobic Gram-negative rods. Journal of Antimicrobial Chemotherapy 10: 279–287 (1982).
Eagle, H. and Newman, E.: The renal clearance of penicillins F, G, K, and X in rabbits and man. Journal of Clinical Investigation 26: 903–918 (1947).
Heinegord, D. and Tiderstrom, G.: Determination of serum creatinine by a direct calorimetric method. Clinica Chimica Acta 43: 305–310 (1973).
Jules, K. and Neu, H.C.: Antibacterial activity and β-lactamase stability of Temocillin. Antimicrobial Agents and Chemotherapy 22: 453–460 (1982).
Lagast, H. and Klastersky, J.: Comparative in-vitro activities of Temocillin and cefazolin against Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 22: 330–331 (1982).
Mattie, H.; Goslings, W.R.O. and Noach, E.L.: Cloxacillin and nafcillin: Serum binding and its relationship to antimicrobial effect in mice. Journal of Infectious Diseases 218: 170–177 (1973).
Nauta, E.H. and Mattie, H.: Dicloxacillin and cloxacillin: Pharmacokinetics in healthy and hemodialysis subjects. Clinical Pharmacology and Therapeutics 20: 98–108 (1976).
Phillips, I.; King, A.; Shannon, K. and Warren, C.: Temocillin (BRL 17421): In-vitro antibacterial activity and susceptibility to β-lactamases. Journal of Antimicrobial Chemotherapy 10: 271–278 (1982).
Piot, P. and Van Dijk, E.: In-vitro activity of BRL 17421 against H. influenzae, N. gonorrhoea and B. catarrhalis. Antimicrobial Agents and Chemotherapy 21: 166–167 (1982).
Scatchard G. The attraction of protein for small molecules and ions. Annals of the New York Academy of Sciences 51: 660–672 (1949).
Slocombe, B.; Basker, M.J.; Bentley, P.H.; Clayton, J.P.; Cole, M.; Comber, K.R.; Dixon, R.A.; Edmonson, R.A.; Jackson, D.; Merrikin, D.J. and Sutherland, R.: BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. Antimicrobial Agents and Chemotherapy 20: 38–46 (1981).
Stephen, K.W. and Speirs, C.F.: Methods for collecting individual components of mixed saliva: The relevance to clinical pharmacology. British Journal of Clinical Pharmacology 3: 315–319 (1976).
Stoeckel, K.; McNamara, P.J.; Brandt, R.; Plozza-Nottebrock, H. and Ziegler, W.H.: Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clinical Pharmacology and Therapeutics 29: 650–657 (1981).
Van Landuyt, H.W.; Pyckavet, M.; Lambert, A. and Boelaert, J.: In-vitro activity of temocillin (BRL 17421), a novel β-lactam antibiotic. Antimicrobial Agents Chemotherapy 22: 535–540 (1982).
Verbist, L: In-vitro activity of temocillin (BRL 17421), a novel β-lactamase-stable penicillin. Antimicrobial Agents and Chemotherapy 22: 157–161 (1982).
Wright, N.; Wise, R. and Price, J.D.: Temocillin elimination in patients with varying degrees of renal failure. Journal of Antimicrobial Chemotherapy 11: 481–484 (1983).
Yourassowsky, C.; van der Linden, M.P.; Lismont, M.J. and Crokaert, F.: Growth curve patterns and bacterial morphology of Escherichia coli subjected to different temocillin (BRL 17421) concentrations. Journal of Antimicrobial Chemotherapy 10: 289–293 (1982).
Author information
Authors and Affiliations
Additional information
Presented only during the poster session.
Rights and permissions
About this article
Cite this article
Overbosch, D., van Gulpen, C. & Mattie, H. Renal Clearance of Temocillin in Volunteers. Drugs 29 (Suppl 5), 128–134 (1985). https://doi.org/10.2165/00003495-198500295-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198500295-00027